INDRAMEDCO vs SHALBY: Stock Comparison
INDRAPRASTHA MEDICAL CORP is the larger company by market capitalisation. INDRAPRASTHA MEDICAL CORP shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
INDRAMEDCO leads 10; SHALBY leads 1 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | INDRAMEDCO | SHALBY |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Hospital | Hospital |
Price
| Metric | INDRAMEDCO | SHALBY |
|---|---|---|
| Live Price | ₹308 | ₹120.84 |
| Day Change | -3.24% | -0.92% |
| Volume | 38,365 | 16,071 |
| 52-Week High | ₹640.85 | ₹252.05 |
| 52-Week Low | ₹293.65 | ₹110.61 |
| Distance from 52W High | -51.94% | -52.06% |
Valuation
| Metric | INDRAMEDCO | SHALBY |
|---|---|---|
| Market Cap | ₹2,827 Cr | ₹1,306 Cr |
| P/E Ratio | 15.51x | 33.71x |
| P/B Ratio | 3.94x | 1.32x |
| EPS | ₹20.51 | ₹1 |
| Book Value | ₹80.78 | ₹93.11 |
| Dividend Yield | 1.28% | 0% |
Growth
| Metric | INDRAMEDCO | SHALBY |
|---|---|---|
| Revenue Growth (TTM YoY) | 9.3% | 8.5% |
| EPS Growth (TTM YoY) | 1.8% | 0% |
| Qtr Sales Growth | 0% | 0% |
| Qtr Profit Growth | 0% | 0% |
Profitability & Leverage
| Metric | INDRAMEDCO | SHALBY |
|---|---|---|
| ROE | 24.8% | 9.05% |
| ROCE | 25.58% | 9.51% |
| Net Margin | 12.21% | 3.28% |
| Operating Margin | 17% | 14.3% |
| Debt to Equity | 0x | 0.1x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | INDRAMEDCO | SHALBY |
|---|---|---|
| Promoter Holding | 49.39% | 74.33% |
| FII Holding | 2.39%▼ 0.38 pp | 4.65%▲ 0.19 pp |
| DII Holding | 1.77%▲ 1.18 pp | 0.31%▲ 0.01 pp |
| Public Holding | 44.84%▼ 0.8 pp | 20.08%▼ 0.18 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: INDRAPRASTHA MEDICAL CORP and SHALBY.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.